NCT07074730 General Anesthesia Versus Spinal Anesthesia With Local Anesthetic Infiltration for Buccal Mucosal Graft in Urethroplasty
| NCT ID | NCT07074730 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | General Anesthesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-07-19 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-07-19 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare general anesthesia and spinal anesthesia with local anesthetic infiltration for buccal mucosal graft (BMG) in urethroplasty.
Eligibility Criteria
Inclusion Criteria: * Male patient age ≥ 21 years. * American Society of Anesthesiologists (ASA) classification I-II. * Patient scheduled for urethroplasty. Exclusion Criteria: * Patients who are taking analgesics for chronic illness or have a history of substance abuse. * Patients who are unable to describe their postoperative pain (e.g., neuropsychiatric disorder). * Patients with known local anesthetics and opioid allergy. * Patients with infection at the site of the needle puncture.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07074730 clinical trial?
This trial is open to male participants only, aged 21 Years or older, studying General Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07074730 currently recruiting?
Yes, NCT07074730 is actively recruiting participants. Contact the research team at 3ed2318@gmail.com for enrollment information.
Where is the NCT07074730 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT07074730 clinical trial?
NCT07074730 is sponsored by Tanta University. The trial plans to enroll 100 participants.